Sleep Disorders current treatment options and market outlook
Narcolepsy: Treatment options and market outlook
sleep-disorders-market-symptoms-risk-factors-types-and-treatment-options
Sleep Disorders: An Emerging Public H...

Sleep is essential for the physical and mental health of the person. If a person didn’t get proper sleep, i...

Narcolepsy drug WAKIX
FDA approves Non-Controlled treatment...

The U.S. Food and Drug Administration has approved WAKIX (pitolisant) to treat excessive daytime sleepiness...

Recent Pharma News
Notizia

Bluebird declares the price of its gene therapy- Zynteglo Bluebird Bio has set the price of its gene t...

machine learning
Machine Learning Models to Help Predicting Cancer Symptoms, Plan Treatment

In what could be regarded as a first of its kind, researchers from the Centre for Vision, Speech and Signal Processing at the University of Surrey in the United Kingdom have recently reported ...


osa
Sleeping at Workplaces: Re-energizing Formula or OSA Disease?

Do you often sleep during work? Well, if you do so, you might proudly claim yourself to be an efficient and hard worker as work stress led you to doze off. Or, you might also advise others to do th...


Narcolepsy: Treatment options and market outlook

Narcolepsy is characterized by symptoms such as excessive daytime sleepiness, cataplexy (sudden loss of muscle control, often triggered by strong emotions) and fragmented sleep. Narcolepsy occurs t...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...